Key Facts Surrounding This News Item
- DVAX had returned -5.88% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.
More Info About Dynavax Technologies Corporation (DVAX)
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, using TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. The company was founded in 1996 and is based in Berkeley, California. View our full DVAX ticker page with ratings, news, and more.